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Astrocytes comprise a large population of cells in the brain and are important partners
to neighboring neurons, vascular cells, and other glial cells. Astrocytes not only form
a scaffold for other cells, but also extend foot processes around the capillaries
to maintain the blood–brain barrier. Thus, environmental chemicals that exist in the
blood stream could have potentially harmful effects on the physiological function of
astrocytes. Although astrocytes are not electrically excitable, they have been shown
to function as active participants in the development of neural circuits and synaptic
activity. Astrocytes respond to neurotransmitters and contribute to synaptic information
processing by releasing chemical transmitters called “gliotransmitters.” State-of-the-art
optical imaging techniques enable us to clarify how neurotransmitters elicit the release
of various gliotransmitters, including glutamate, D-serine, and ATP. Moreover, recent
studies have demonstrated that the disruption of gliotransmission results in neuronal
dysfunction and abnormal behaviors in animal models. In this review, we focus on
the latest technical approaches to clarify the molecular mechanisms of gliotransmitter
exocytosis, and discuss the possibility that exposure to environmental chemicals could
alter gliotransmission and cause neurodevelopmental disorders.
Keywords: astrocytes, exocytosis, glial cell, gliotransmitter, neurodevelopmental disorders, optical imaging,
synaptic activity
INTRODUCTION
Astrocytes are the most abundant glial cells in the central nervous system (CNS) of mammals
(Ventura and Harris, 1999). Based on electron microscopic analyses, astrocytes are located near
to neurons and blood vessels (Figure 1A). Regarding vasculature, capillary endothelial cells
are surrounded by pericytes and basal lamina, and astrocytes tightly wrap these microvascular
structures (Abbott et al., 2006). Together with pericytes, astrocytes are an essential component
of the blood–brain barrier (BBB), which selects and transports molecules from the bloodstream,
and allows for the transfer of nutrients to neurons (Figure 1B). Regarding their relationship
with neurons, astrocytic foot processes make close contact with pre- and post-synaptic areas,
forming structures called “tripartite synapses” (Araque et al., 1999; Halassa et al., 2007). Indeed,
in the hippocampus, 57% of synapses are associated with astrocytes (Ventura and Harris, 1999),
suggesting that astrocytes might contribute to neural information processing in the CNS.
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Despite their morphological characteristics described above,
astrocytes have long been considered as mere metabolic
supporters that nurture adjacent neurons (Halassa et al., 2007;
Wang and Bordey, 2008; Calì et al., 2009). However, recent
electrophysiology and optical imaging analyses have provided
strong evidence that astrocytes respond to neurotransmitters
and release chemical transmitters called “gliotransmitters” (Li
et al., 2013). Gliotransmitters, including glutamate, D-serine,
and ATP, bind to their respective receptors on neurons to
modulate their firing frequency and/or synaptic transmission
(Figure 1C; Halassa et al., 2007; Koizumi, 2010). In fact, the
dysfunction of gliotransmitter release-related proteins (e.g.,
vesicular transporters and vesicle-associatedmembrane proteins)
in astrocytes can cause serious brain disorders and abnormal
behaviors (Rossi et al., 2011; Verkhratsky et al., 2014). At
the same time, traumatic injury, stroke, or infection-induced
astrogliosis (also known as reactive astrocytes). These reactive
astrocytes produce and release neurotoxic levels of glutamate
(Rossi et al., 2011; Verkhratsky et al., 2014). Astrocytes also
contribute to proper development of the BBB by aligning
endothelial cells and pericytes, transporting molecules selected
from the bloodstream to neurons (Abbott et al., 2006), and
providing a protective barrier against toxic substances (Pentreath
and Slamon, 2000; Calabrese, 2008). Thus, chronic exposure
to environmental chemicals, or inflammatory molecules from
vasculature, may potentially affect the function of astrocytes and
gliotransmitter release (Kim et al., 2014; Orellana et al., 2014;
Avendano et al., 2015).
In this review, we present the latest methods that
enable scientists to decipher the molecular mechanisms of
gliotransmitter secretion. In particular, we focus on the vesicular
exocytosis of gliotransmitters from astrocytes using optical
microscopic imaging.We further discuss how genetic alterations,
acute injuries, and chronically toxic conditions (including
exposure to stress in utero) could impair gliotransmission and
consequently lead to neuronal and behavioral disorders.
MOLECULAR MECHANISMS UNDERLYING
THE RELEASE OF GLIOTRANSMITTERS
There have been two major methodological breakthroughs that
have allowed for profound understanding of astrocytic activities
including gliotransmission: calcium imaging and advanced
optical microscopy (Li et al., 2013). The initial discovery made
by using chemical calcium indicators was that astrocytes exhibit
increased intracellular calcium concentration ([Ca2+]i), which
spreads to adjacent astrocytes. This phenomenon is called Ca2+
waves (Cornell-Bell et al., 1990; Charles et al., 1991; Rusakov
et al., 2014). Genetically encoded calcium indicators have enabled
more detailed analysis of astrocyte functions (Shigetomi et al.,
2013).
Two-photon microscopy enabled scientists to observe
fluorescence with superior penetration depth. Thus, studies on
astrocytes have been expanded to experiments using brain slices
and in vivomodels (Nimmerjahn et al., 2004; Nishida and Okabe,
2007). Moreover, thanks to total internal reflection fluorescence
FIGURE 1 | Astrocytes have close morphological and functional
associations with microvasculature and neurons. (A) Location of
astrocytes around blood vessels and neurons in the central nervous system.
Note that single astrocytes make contact with a large number of blood vessels
and neurons through their numerous processes. (B) Schematic diagram
showing the blood–brain barrier and its functions in selecting and transporting
various molecules from the blood stream. Although, vascular endothelial cells
form robust tight junctions that prevent infiltration of most soluble molecules,
hydrophobic lipids can penetrate across the plasma membrane. In addition,
certain soluble molecules such as glucose are actively transported across the
endothelial cells via their specific transporters, and some peptides are taken
up by selective vesicular transcytosis. (C) Schematic diagram showing the
tripartite synapse and complex signaling interactions mediated by
neurotransmitters and gliotransmitters. Neurotransmitters released from
presynaptic terminals such as glutamate act not only on postsynapses but
also on astrocytes. Activated astrocytes release gliotransmitters including
glutamate, D-serine, and ATP, via vesicular exocytosis (and also possibly via
hemichannels for ATP). Released gliotransmitters bind to presynaptic and
postsynaptic receptors to regulate synaptic transmission. Astrocytes also take
part in clearance of extracellular glutamate via glutamate transporters.
microscopy, which can visualize fluorescent molecule behaviors
beneath the plasma membrane, the interaction between [Ca2+]i
elevation and subsequent vesicular trafficking became precisely
clarified (Bezzi et al., 2004; Shigetomi et al., 2012; Oya et al.,
2013).
Because of these experimental advancements, accumulating
evidence suggests the paradigm that: (1) inositol 1,4,5-
trisphosphate-mediated Ca2+ release from endoplasmic
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reticulum causes [Ca2+]i increases in astrocytes in response
to the activity of adjacent astrocytes and neurons; (2) elicited
[Ca2+]i elevation induces release of gliotransmitters (Halassa
et al., 2007; Oya et al., 2013; Khakh and McCarthy, 2015).
Although the exact mechanisms of gliotransmission are unclear,
recent studies have partially revealed the release mechanisms
of glutamate, D-serine, and ATP in astrocytes (Figure 2; Gucek
et al., 2012; Li et al., 2013).
GLUTAMATE
Although, glutamate is well-known as a neurotransmitter, it also
acts as a gliotransmitter. Application of bradykinin to cultured
astrocytes induces glutamate release and influences adjacent
neurons through N-methyl-D-aspartate (NMDA) receptors
(Parpura et al., 1994). In contrast, application of clostridium,
tetanus, and botulinum neurotoxins, which differentially
cleave the exocytosis-regulating soluble N-ethylmaleimide-
sensitive factor attachment protein receptor (SNARE) proteins,
reduces Ca2+-dependent glutamate release. These findings
suggest that the SNARE proteins, including vesicle-associated
membrane protein-2 (VAMP2), syntaxin-1, and synaptosome-
associated protein-23, mediate Ca2+-dependent glutamate
release (Montana et al., 2006; Parpura and Zorec, 2010).
The uptake of cytoplasmic glutamate into exocytotic vesicles
is mediated by vesicular glutamate transporters (VGLUTs),
which are driven by a proton gradient produced by vacuolar-
type H+ ATPases (V-ATPases; Takamori et al., 2000; Gucek
et al., 2012). Inhibition of V-ATPases blocks Ca2+-dependent
glutamate release (Parpura and Zorec, 2010). Furthermore,
FIGURE 2 | Precise intracellular machinery involved in the release of glutamate, D-serine, and ATP from astrocytes. Glutamate and D-serine are taken up
into synaptic-like vesicles through (1) VGLUT and (2) vesicular D-serine transporters (VSERT), respectively. These synaptic-like vesicles fuse to the plasma membrane,
mediated by SNARE proteins including VAMP2 or VAMP3, in response to [Ca2+]i increase. In contrast, ATP is released through secretory lysosomes. Storage of ATP
into secretory lysosomes is achieved by (3) VNUT. Through the interaction of SNARE proteins including TI-VAMP, ATP-containing secretory lysosomes are
Ca2+-dependently exocytosed. Moreover, the existence of other release mechanisms has been discovered: (4) reverse operation of plasma membrane glutamate
transporters, (5) cell swelling-induced anion transporter (VRAC) opening, (6) release via P2X7 receptors, and (7) gap junction channels (hemichannels) on the cell
surface of astrocytes.
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VGLUT1 and 2 are colocalized with synaptic-like vesicles (Bezzi
et al., 2004), suggesting that glutamate is packaged into synaptic-
like vesicles and released from astrocytes in a Ca2+-dependent
manner.
Meanwhile, other release mechanisms have been identified:
(1) reverse operation of plasma membrane glutamate
transporters (Longuemare and Swanson, 1995); (2) cell
swelling-induced anion transporter opening (Kimelberg et al.,
1990); (3) release via P2X7 receptors (Duan et al., 2003); (4)
gap junction channels (i.e., hemichannels) on the cell surface of
astrocytes (Ye et al., 2003). However, it is not clear how often and
to what extent astrocytes employ these different mechanisms.
Further studies will be needed to clarify whether there are specific
release mechanisms that operate under particular conditions.
D-SERINE
The discovery of D-serine as a gliotransmitter was remarkable
because it was long thought that mammalian tissues only
produced L-isomers of amino acids (Oliet and Mothet, 2006;
Henneberger et al., 2012). D-serine is thought to be produced
from L-serine by serine racemase (de Miranda et al., 2002). In
cultured astrocytes, application of glutamate enhanced Ca2+-
dependent secretion of D-serine via the activation of α-amino-
3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate
receptors (AMPA/KARs) and metabotropic glutamate receptors
(Mothet et al., 2005). Correspondingly, agonists for AMPA/KARs
and metabotropic glutamate receptors were found to increase
[Ca2+]i as well as subsequent secretion of D-serine, which is
reduced by inhibition of these receptors. Furthermore, tetanus
neurotoxins and V-ATPase inhibitors suppress agonist-evoked
secretion of D-serine, and VAMP2/3 and VGLUT2-containing
vesicles that are colocalized with D-serine. These results suggest
that D-serine is stored in the synaptic-like vesicles and released
from the vesicles in a Ca2+-dependent manner (Martineau et al.,
2013).
ATP
Although ATP is the primary energy currency of the cells,
ATP can also act as a signaling molecule through purinergic
receptors. A recent study showed that culture medium from
cultured astrocytes exhibiting Ca2+ waves contained more ATP
than control culture medium. Interestingly, the addition of
collected culture medium to astrocytes induced Ca2+ waves that
were inhibited by purinergic receptor antagonists (Guthrie et al.,
1999). Thus, the ATP released from astrocytes induces Ca2+
waves, which astrocytes use to communicate with each other.
However, the ATP release mechanisms still remain controversial;
several lines of investigation have suggested various putative
models for ATP release from astrocytes (Koizumi, 2010).
Connexin 43 (Cx43) assembles into a hemichannel which
constitutes gap junctions in astrocytes, and exchanges
signaling molecules, including Ca2+ and inositol 1,4,5-
trisphosphate,between adjacent astrocytes (Orellana and
Stehberg, 2014). Bioluminescence imaging of ATP combined
with single channel recording showed that Cx43 hemichannels
in rat glioma C6 cells and CA1 hippocampal astrocytes are
permeable to ATP (Kang et al., 2008). Consistent with this
finding, glutamate evoked [Ca2+]i increase and ATP release
in astrocytes of hippocampal slices, which were inhibited
by application of a hemichannel blocker and in Cx43/Cx30
knockout mice (Torres et al., 2012), suggesting that ATP is
released extracellularly through Cx43 hemichannels.
However, some studies have shown the involvement of
secretory lysosomes in ATP release from astrocytes. In fact,
primary cultured astrocytes express a secretory lysosome marker
called vesicle-associated membrane protein-7 (also called TI-
VAMP), and TI-VAMP-positive secretory lysosomes contain ATP
which is Ca2+-dependently released (Verderio et al., 2012). In
an experiment using primary cultured astrocytes and C6 cells,
vesicular nucleotide transporter (VNUT)-positive lysosomes
were labeled with fluorescent ATP, and application of VNUT
inhibitor reduced the number of fluorescent ATP-containing
vesicles. Observation by total internal reflection fluorescence
microscopy revealed exocytotic events of secretory lysosomes in
the cells following the application of a calcium ionophore, ATP,
and glutamate. Thus, ATP is stored in lysosomes and released
from lysosomes in a Ca2+-dependent manner (Oya et al., 2013).
CONTRIBUTION OF GLIOTRANSMITTER
RELEASE TO DEVELOPMENT AND
DISEASE
Release of gliotransmitters regulates synaptic transmission
between neurons and the extracellular environment in the
brain. It is known that glutamate and D-serine excite synaptic
transmission. However, whether ATP potentiates or inhibits
synaptic transmission is still under debate because adenosine,
a metabolite synthesized from ATP, usually inhibits synaptic
activity via adenosine A1 receptors (Koizumi, 2010; Nam et al.,
2012; Delekate et al., 2014). It is therefore reasonable to speculate
that imbalance in the release of these gliotransmitters could result
in altered neuronal activity. Various pathological conditions,
including CNS diseases, traumatic brain injuries, developmental
disorders, and prenatal exposure to deleterious molecules have
been reported to be closely associated with impairment of
gliotransmission.
CNS DISEASES
Many CNS diseases are attributed to hyperactivity of neurons
or unregulated neuronal cell death. Although such conditions
have long been the focus of “neurocentric” studies, recent
progress in the study of astrocytic gliotransmission has provided
accumulating evidence for the contribution of astrocytes (Rossi
et al., 2011; Verkhratsky et al., 2014).
Epilepsy is one of the most common CNS diseases, and is
characterized by sudden and frequent seizures resulting from
excessive firings by neurons (Wetherington et al., 2008). In
slices from epilepsy model mice, astrocytic glutamate release
was found to cause abnormal and prolonged depolarization in
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neurons (Tian et al., 2005). Furthermore, tumor necrosis factor-
α (TNFα) and prostaglandins (PGs), released from astrocytes
under traumatic events, can reactivate their calcium signaling,
and can cause increased glutamate release (Bezzi et al., 1998,
2001; Domercq et al., 2006).
Reactive astrocytes are also involved in the pathogenesis of
other neuronal disorders. In a mouse model of Huntington’s
disease, cultured astrocytes exhibited hyperactivated Ca2+-
dependent glutamate release. This activity was owing to
increased expression of pyruvate carboxylase (Lee et al., 2013),
or reduced expression of glutamate transporter-1 and Kir4.1
K+ channels, which are key regulators for the clearance
of extracellular glutamate and maintenance of membrane
potentials, respectively (Behrens et al., 2002; Tong et al., 2014).
In addition to overpotentiating neuronal activity, excessive
accumulation of extracellular glutamate causes cytotoxicity. For
instance, mice with genetic deletion in glutamate transporter-
1 exhibit reduced glutamate clearance, and consequently
display abnormal cell death in motor neurons, reminiscent
of amyotrophic lateral sclerosis (Staats and Van Den Bosch,
2009).
In Alzheimer’s disease (AD) mouse models, reactive
astrocytes are detected near β-amyloid plaques (Nagele et al.,
2004). Although chronic rise in [Ca2+]i is a well-known
phenomenon in reactive astrocytes in AD, its underlying
mechanisms remain unclear. A recent study demonstrated
that purinergic signaling through Cx43 hemichannels and
P2Y1 receptors mediated the hyperactivity of astrocytes in
AD (Delekate et al., 2014). Consistent with this finding,
upregulation of Cx43 hemichannels was observed in an
AD mouse model (Mei et al., 2010), and AD patients
displayed higher levels of ATP in brain regions surrounding
β-amyloid plaques (Mecheri et al., 1997; Mandal et al.,
2012).
Gliotransmitter release from astrocytes is also required
for correct development of neuronal circuits. In particular,
glial-neuronal communication through NMDA receptors is
an essential process for proper dendritic morphogenesis and
establishment of synaptic connections (Rabacchi et al., 1992;
Sin et al., 2002; Espinosa et al., 2009). Although NMDA
receptors are activated by both glutamate and D-serine,
recent discoveries suggest that D-serine plays an important
role in dendritic development and long-term potentiation
(Henneberger et al., 2010; Devito et al., 2011; Balu and
Coyle, 2012; Diniz et al., 2012). Mice with a deletion of
serine racemase showed reduced levels of brain D-serine and
brain-derived neurotrophic factor, and loss of glutamatergic
neurotransmission, and consequently had less complex dendrites
(Morita et al., 2007; Balu and Coyle, 2012). Because NMDA
receptor malfunction has been considered to be responsible for
schizophrenia, deficiency in D-serine secretion from astrocytes
can be a potent schizophrenia risk factor (Van Horn et al., 2013).
Indeed, association studies of schizophrenia patients revealed
several mutations in genes for serine racemase, as well as D-
amino acid oxidase and its interacting protein G72 (Boks et al.,
2007; Morita et al., 2007; Müller et al., 2011; Caldinelli et al.,
2013).
INJURY AND INFECTION
Acute brain insults, caused by ischemia or infection, affect
neuronal circuitry through direct inflammatory responses in
neurons and through signals from glial cells (Vesce et al.,
2007; Calì et al., 2009). Astrocytes under acute inflammatory
conditions undergo reactive astrogliosis similarly to those in
CNS diseases, albeit with differences in gene expression and cell
structure (Khakh and Sofroniew, 2015). Upon injury or ischemia,
damaged neurons, endothelial cells and glial cells are known
to release considerable amounts of ATP (Cook and McCleskey,
2002; Wang et al., 2004; Davalos et al., 2005; Nedergaard
et al., 2010). Increased levels of extracellular ATP activate
purinergic receptors on astrocytes, particularly P2Y1 (Domercq
et al., 2006), thereby inducing [Ca2+]i elevation and release of
glutamate, as well as ATP (Domercq et al., 2006; Nedergaard
et al., 2010). Furthermore, inflammatory molecules including
TNFα, interleukin-1β, and PGs, are profoundly engaged in these
responses. Not only the activated microglia converge to the site
of injury and secrete cytokines; astrocytes themselves synthesize
TNFα and PGs (Domercq et al., 2006; Santello et al., 2011). TNFα
and PGs either interact with certain processes in the stimulus–
secretion coupling machinery within astrocytes (Domercq et al.,
2006; Santello et al., 2011), or bind to TNFα and PGs receptors
on astrocytes after secretion (Bezzi et al., 2001; Vesce et al., 2007).
CHRONIC AND PRENATAL EXPOSURE TO
CHEMICALS
Increasing evidence shows significant correlations between
environmentally deleterious chemicals and the risk of
neurodevelopmental disorders (Feng et al., 1990; Leonardsson
and Ny, 1997). Previous studies have focused on the effects
of toxic substances on neurons, but recently it was suggested
that astrocytes are also involved in the pathogenesis of those
conditions.
Owing to their close connections with microvascular units
via BBB, astrocytes tend to be chronically exposed to noxious
molecules in circulation. Probably because of their interactions
with environmental toxins, astrocytes possess more resilient
and adaptive machinery against toxic molecules compared with
neurons (Pentreath and Slamon, 2000; Calabrese, 2008). These
protective systems include the glutathione system, superoxide
dismutase, and hemeoxygenase (Dwyer et al., 1995; Huang and
Philbert, 1995; Blaauwgeers et al., 1996; Pentreath and Slamon,
2000). Nevertheless, excessive passage of harmful substances
across the BBB seriously affects astrocyte homeostasis and
functionality.
The toxicological effects of heavy metals (e.g., mercury, zinc,
manganese, and aluminum) on neurons and glial cells have been
studied for decades (Calabrese, 2008; De Keyser et al., 2008).
However, it is unclear how these metals affect gliotransmitter
release. Some studies have shown that lead and manganese
induce cytotoxic cell death by impairing glutamate uptake in
astrocytes (Normandin and Hazell, 2002; Struzynska et al., 2005).
However, pathological effects on gliotransmission by lifestyle-
associated factors, such as smoking, drinking, and insufficient
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sleep, are becoming the focus of growing interest. Because
nicotinic acetylcholine receptors are expressed on astrocytes, they
exhibit nicotine sensitivity and [Ca2+]i increase (Oikawa et al.,
2005; Delbro et al., 2009). Ethanol causes reactive oxygen species
production, and [Ca2+]i increase and glutamate secretion from
astrocytes (Salazar et al., 2008). Astrocytes exposed to ethanol
also exhibit alterations in Golgi complex morphology, secretory
vesicle biogenesis, and expression levels of Rab GTPases and
motor proteins (Tomas et al., 2005), which may be an additional
factor for the dysfunction of brain development caused by
ethanol.
Because adenosine plays a critical role in the control
of sleep-wakefulness (Thakkar et al., 2003), and chronic
alcoholism is frequently accompanied by sleep disorders
(Brower, 2001), changes in sleep pattern may also induce
alteration in gliotransmitter release. Interestingly, hypothalamic
astrocytes from rats following sleep deprivation exhibited
different proteome profiles, and the expression of VAMP2, which
is an essential protein for vesicular exocytosis (Kim et al.,
2014), was significantly increased. These findings suggest a
strong association between alcohol intake, sleep disorders, and
astrocytic gliotransmission.
Additionally, certain ambient ultrafine particles, which
are defined as particulate substances with a diameter less
than 100 nm, are emerging as another toxic substance that
may deleteriously affect brain function (Block and Calderón-
Garcidueñas, 2009; Loane et al., 2013). In a recent study, ultrafine
carbon black, a surrogate for ultrafine particles, was shown
to induce the release of glutamate and ATP from astrocytes
by activating Cx43 and pannexin-1 hemichannels (Wei et al.,
2014).
Recent epidemiological and experimental studies have
demonstrated that children born from mothers who are exposed
to infections or are addicted to alcohol or drugs have a higher
risk of neuronal disorders and abnormal behaviors (Jacobsen
et al., 2006; Stringari et al., 2008; Boksa, 2010; Brolese et al.,
2015). However, the effects of these agents on astrocytes still
remain largely unknown. Some studies have shown that prenatal
exposure to lipopolysaccharides or nicotine together with
postnatal high-fat/cholesterol diet result in enhancement of
Cx43 hemichannel activity, and consequently increases the
release of glutamate and ATP (Orellana et al., 2014; Avendano
et al., 2015).
CONCLUSIONS
Over several decades, researchers have attempted to understand
the properties and pathologies of the CNS by focusing solely
on neurons; however, recent improvements in molecular and
cellular imaging techniques are increasingly indicating that
this neurocentric approach needs to be revised. In addition
to neurons, glial cells including astrocytes are important
elements for brain functions. Astrocytes are located in close
morphological and functional relationships with blood vessels
and neurons, and various genetic or environmental factors are
implicated in gliotransmission impairment. Considering these
characteristics of astrocytes, further studies will provide new
insight on the significance of gliotransmitter release for fetal
neurodevelopment. Thus, new therapies can be developed to
overcome environmental chemical-induced neurodevelopmental
disorders.
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